Patient characteristics.

<p>Patient characteristics.</p

Prevalence of deleterious variants within subgroups.

<p>Prevalence of deleterious variants within subgroups.</p

Histologic subtypes and prevalence of deleterious variants in patients with serous, endometrioid, mucinous or clear cell ovarian cancer.

<p>Histologic subtypes and prevalence of deleterious variants in patients with serous, endometrioid, mucinous or clear cell ovarian cancer.</p